Search | LIFE-ND Graduate Community

added blog Health

2026-07-07 09:54:55 -

The Acemetacin Market is poised for steady growth, valued at USD 700 million in 2024 and projected to reach USD 1,200 million by 2035 at a CAGR of 4.4%. Acemetacin, a non-steroidal anti-inflammatory drug (NSAID), is widely prescribed for pain management, anti-inflammatory treatment, rheumatoid arthritis, osteoarthritis, and postoperative pain. Its favorable safety profile compared to...

0 Comments 0 Shares 83 Views 0 Reviews